Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2005
Naturally acquired MAGE-A10- and SSX-2-specific CD8+ T cell responses in patients with hepatocellular carcinomaGabriel Bricard, Hanifa Bouzourene, Olivier Martinet, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 29, 2010
Impact of 3 different short-term chemotherapy regimens on lymphocyte-depletion and reconstitution in melanoma patientsJulien Laurent, Daniel E Speiser, Victor Appay, et al.
The Journal of Clinical Investigation|April 16, 2004
An immunodominant SSX-2-derived epitope recognized by CD4+ T cells in association with HLA-DRMaha Ayyoub, Charles S Hesdorffer, Monica Montes, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2002
Functional avidity of tumor antigen-specific CTL recognition directly correlates with the stability of MHC/peptide multimer binding to TCRValérie Dutoit, Verena Rubio-Godoy, Marie-Agnès Doucey, et al.
International Journal of Cancer|June 12, 2008
Infrequent promoter methylation of the MGMT gene in liver metastases from uveal melanomaVerena Voelter, Annie-Claire Diserens, Alexandre Moulin, et al.
Clinical Immunology (Orlando, Fla.)|December 15, 2004
Distinct but overlapping T helper epitopes in the 37-58 region of SSX-2Maha Ayyoub, Andrea Merlo, Charles S Hesdorffer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 2, 2002
Proteasome-assisted identification of a SSX-2-derived epitope recognized by tumor-reactive CTL infiltrating metastatic melanomaMaha Ayyoub, Stefan Stevanovic, Ugur Sahin, et al.
European Journal of Immunology|September 5, 2002
Combinatorial peptide library-based identification of peptide ligands for tumor-reactive cytolytic T lymphocytes of unknown specificityVerena Rubio-Godoy, Maha Ayyoub, Valerie Dutoit, et al.
Pageof 7